Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65

Cited In for PubMed (Select 15361874)

1.

Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.

Cani A, Simioni C, Martelli AM, Zauli G, Tabellini G, Ultimo S, McCubrey JA, Capitani S, Neri LM.

Oncotarget. 2015 Mar 30;6(9):6597-610.

2.

The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.

Zweier-Renn LA, Riz I, Hawley TS, Hawley RG.

J Bone Marrow Res. 2013 Feb 20;1. pii: 105.

3.

NUP214 fusion genes in acute leukemia (Review).

Zhou MH, Yang QM.

Oncol Lett. 2014 Sep;8(3):959-962. Epub 2014 Jun 18.

4.

Nuclear transport of galectin-3 and its therapeutic implications.

Funasaka T, Raz A, Nangia-Makker P.

Semin Cancer Biol. 2014 Aug;27:30-8. doi: 10.1016/j.semcancer.2014.03.004. Epub 2014 Mar 19. Review.

PMID:
24657939
5.

Development of detection method for novel fusion gene using GeneChip exon array.

Wada Y, Matsuura M, Sugawara M, Ushijima M, Miyata S, Nagasaki K, Noda T, Miki Y.

J Clin Bioinforma. 2014 Feb 18;4(1):3. doi: 10.1186/2043-9113-4-3.

6.

Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.

Atak ZK, Gianfelici V, Hulselmans G, De Keersmaecker K, Devasia AG, Geerdens E, Mentens N, Chiaretti S, Durinck K, Uyttebroeck A, Vandenberghe P, Wlodarska I, Cloos J, Foà R, Speleman F, Cools J, Aerts S.

PLoS Genet. 2013;9(12):e1003997. doi: 10.1371/journal.pgen.1003997. Epub 2013 Dec 19.

7.

NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells.

Dos Santos NR, Ghezzo MN, da Silva RC, Fernandes MT.

Cancers (Basel). 2010 Nov 5;2(4):1838-60. doi: 10.3390/cancers2041838.

8.

Identification of interconnected markers for T-cell acute lymphoblastic leukemia.

Maiorov EG, Keskin O, Ng OH, Ozbek U, Gursoy A.

Biomed Res Int. 2013;2013:210253. doi: 10.1155/2013/210253. Epub 2013 Jul 15.

9.

Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia.

Iacobucci I, Lonetti A, Papayannidis C, Martinelli G.

Curr Cancer Drug Targets. 2013 Sep;13(7):791-810. Review.

10.

NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.

De Keersmaecker K, Porcu M, Cox L, Girardi T, Vandepoel R, de Beeck JO, Gielen O, Mentens N, Bennett KL, Hantschel O.

Haematologica. 2014 Jan;99(1):85-93. doi: 10.3324/haematol.2013.088674. Epub 2013 Jul 19.

11.

The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy.

Tosello V, Ferrando AA.

Ther Adv Hematol. 2013 Jun;4(3):199-210. doi: 10.1177/2040620712471368.

12.

Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.

Van Vlierberghe P, Ambesi-Impiombato A, De Keersmaecker K, Hadler M, Paietta E, Tallman MS, Rowe JM, Forne C, Rue M, Ferrando AA.

Blood. 2013 Jul 4;122(1):74-82. doi: 10.1182/blood-2013-03-491092. Epub 2013 May 17.

13.

Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic.

Mullighan CG, Willman CL.

J Adolesc Young Adult Oncol. 2011 Jun;1(2):77-86.

14.

Genome Fusion Detection: a novel method to detect fusion genes from SNP-array data.

Thieme S, Groth P.

Bioinformatics. 2013 Mar 15;29(6):671-7. doi: 10.1093/bioinformatics/btt028. Epub 2013 Jan 22.

15.

Structure, regulation, signaling, and targeting of abl kinases in cancer.

Hantschel O.

Genes Cancer. 2012 May;3(5-6):436-46. doi: 10.1177/1947601912458584.

16.

Genetic technologies in cancer investigation - applications in aggresive lymphoid malignancies.

Berbec NM, Arghir A, Vitcu A, Angelescu S, Colita Amd A, Ciobanu A, Papuc SM, Tutlan-Cunita AC, Lupu AR.

Maedica (Buchar). 2012 Jan;7(1):75-9. No abstract available.

17.

The new nucleoporin: regulator of transcriptional repression and beyond.

Sarma NJ, Willis K.

Nucleus. 2012 Nov-Dec;3(6):508-15. doi: 10.4161/nucl.22427. Epub 2012 Oct 9.

18.

The molecular basis of T cell acute lymphoblastic leukemia.

Van Vlierberghe P, Ferrando A.

J Clin Invest. 2012 Oct;122(10):3398-406. doi: 10.1172/JCI61269. Epub 2012 Oct 1. Review.

19.

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X, Chen SC, Payne-Turner D, Churchman ML, Harvey RC, Chen X, Kasap C, Yan C, Becksfort J, Finney RP, Teachey DT, Maude SL, Tse K, Moore R, Jones S, Mungall K, Birol I, Edmonson MN, Hu Y, Buetow KE, Chen IM, Carroll WL, Wei L, Ma J, Kleppe M, Levine RL, Garcia-Manero G, Larsen E, Shah NP, Devidas M, Reaman G, Smith M, Paugh SW, Evans WE, Grupp SA, Jeha S, Pui CH, Gerhard DS, Downing JR, Willman CL, Loh M, Hunger SP, Marra MA, Mullighan CG.

Cancer Cell. 2012 Aug 14;22(2):153-66. doi: 10.1016/j.ccr.2012.06.005.

20.

Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Shang B, Zhang G, Pan Y, Zhou Q.

Cancer Microenviron. 2012 Dec;5(3):211-23. doi: 10.1007/s12307-012-0108-9. Epub 2012 May 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk